ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 441,76
0,16%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Neuronetics Inc (STIM)

  7. Neuronetics Inc (STIM) Actualités

STIM Neuronetics Inc

2,24
0,21 (10,34%)
08 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Neuronetics Inc STIM NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,21 10,34% 2,24 00:23:28
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,12 2,11 2,28 2,24 2,03
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/6/202412:05EDGAR2Form 8-K - Current report
06/6/202402:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:00EDGAR2Form 8-K - Current report
30/5/202422:01EDGAR2Form SD - Specialized disclosure report
23/5/202414:30GLOBENeuronetics to Present at the William Blair 44th Annual..
15/5/202413:32GLOBEHumana Is First Commercial Payer to Address TMS Therapy..
07/5/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:31EDGAR2Form 8-K - Current report
07/5/202413:30EDGAR2Form 8-K - Current report
07/5/202413:30GLOBENeuronetics Reports Record First Quarter 2024 Financial and..
03/5/202422:30GLOBENeuronetics Reports Inducement Grant Under Nasdaq Listing..
01/5/202414:31GLOBENeuroStar® TMS Advances Treatment for Adolescents During..
23/4/202422:30GLOBENeuronetics to Report First Quarter 2024 Financial and..
10/4/202414:31GLOBENew Publication in Brain Stimulation Confirms Full TMS..
27/3/202421:30GLOBENeuronetics Reports Inducement Grant Under Nasdaq Listing..
25/3/202413:30GLOBENeuroStar® Advanced Therapy Receives FDA Clearance as a..
07/3/202414:22GLOBENeuronetics Announces 5-Year Exclusive Partnership with..
06/3/202422:01EDGAR2Form 8-K - Current report
05/3/202413:31EDGAR2Form 8-K - Current report
05/3/202413:30EDGAR2Form 8-K - Current report
05/3/202413:30GLOBENeuronetics Reports Record Fourth Quarter and Record Full..
01/3/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:10EDGAR2Form 144 - Report of proposed sale of securities
28/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:48EDGAR2Form 144 - Report of proposed sale of securities
28/2/202422:16EDGAR2Form 144 - Report of proposed sale of securities
27/2/202423:33EDGAR2Form 144 - Report of proposed sale of securities
26/2/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:54EDGAR2Form 144 - Report of proposed sale of securities
23/2/202422:23EDGAR2Form 144 - Report of proposed sale of securities
22/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:14EDGAR2Form 144 - Report of proposed sale of securities
20/2/202421:19EDGAR2Form 144 - Report of proposed sale of securities
20/2/202414:30GLOBENeuronetics to Report Fourth Quarter 2023 Financial and..
16/2/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:35EDGAR2Form 144 - Report of proposed sale of securities
14/2/202417:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202417:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202414:32GLOBENeuronetics Launches Latest Evolution in its TrakStar®..
09/2/202421:39EDGAR2Form 144 - Report of proposed sale of securities
08/2/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:44EDGAR2Form 144 - Report of proposed sale of securities
06/2/202422:24EDGAR2Form 144 - Report of proposed sale of securities
06/2/202414:28GLOBENeuroStar TMS Patient Access Expands Through Lucet Health..

Dernières Valeurs Consultées

NASDAQ
STIM
Neuronetics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés